PL02.08 Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers
2019
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
52
Citations
NaN
KQI